Charles H Hood Foundation

The Charles H. Hood Foundation, incorporated in 1942 and headquartered in Manchester, Massachusetts, operates as a precision instrument for pediatric health research funding — not a broad philanthropic enterprise. Its mission is explicitly catalytic: to identify innovative pediatric advancements and fund them during high-risk critical development phases when mainstream funders are reluctant to commit. This philosophy shapes every dimension of how the Foundation awards grants.

The Foundation deliberately targets the career stage before researchers have established an independent funding track record. PhD scientists within five years of completing training and physician-scientists within seven years represent the entire eligible applicant pool for Child Health Research Awards. These windows function as absolute eligibility gates, not preferences. The Foundation's theory of change is that well-chosen grants at this inflection point produce outsized scientific careers — Boston Children's Hospital (19 Hood-funded grants), Yale University (11), and Massachusetts General Hospital (7) in the grantee database reflect the compounding returns of early-career investment.

Geographically, the Foundation concentrates nearly all research grant funding within the six New England states. Analysis of 98 grantee records reveals that Massachusetts accounts for 65% of grants (64 of 98), Connecticut 17% (17 grants), New York 7%, Rhode Island 5%, and New Hampshire 4%. Researchers at institutions outside this footprint are categorically ineligible for standard research awards, though the CH Innovations program for for-profit companies operates globally.

Institutionally, the Foundation favors elite academic medical centers and research universities with established research infrastructure. No community organization or non-research nonprofit appears in the top grantee list. First-time applicants should have primary appointments at recognized medical schools, teaching hospitals, or research universities with robust grants administration capacity.

The standard relationship with the Foundation begins and often ends with the online application — there is no formal cultivation stage or relationship-building pathway for standard awards. However, the Foundation's new $15 million Hood Pediatric Innovation Hub at MIT (launched April 2025) opens a distinct relationship pathway for researchers interested in technology translation and pediatric device development. For CH Innovations (program-related investments), initial contact is through an Airtable form submission rather than a structured proposal.

No officer compensation has been listed in IRS filings since at least 2016, reflecting a lean governance structure where trustees — including President Neil Smiley, VP John O. Parker Jr., and longtime trustee Charlene Maria Mancusi — operate as active stewards rather than passive overseers. The February 2026 appointment of Dr. Camilia R. Martin as the Foundation's first publicly identified Chief Scientific Officer signals a meaningful shift toward more formalized scientific portfolio management.

The Charles H. Hood Foundation distributes grants on a consistent biannual schedule, with funding cycles commencing each January 1 and July 1. The standard Child Health Research Award is $200,000 per grant — distributed over two years at approximately $100,000 per year, inclusive of 10% indirect costs. Five grants are awarded per cycle, generating up to 10 new awards annually and approximately $2 million in new two-year commitments per year.

Historical financial data confirms the reliability of this pattern. Grants paid totaled $2,150,250 in FY2023, $2,662,000 in FY2022, $2,365,000 in FY2021, $2,059,212 in FY2020, and $2,125,000 in FY2019. Total annual giving (including program-related expenses) has ranged from $2.46 million (FY2020) to $3.33 million (FY2022), with a median of approximately $2.5 million across the five most recent reporting years. Year-to-year variation reflects timing of Major Grant disbursements rather than fundamental policy shifts.

Within the 98-grant grantee database (total: $9,533,462; average per grant: $97,280), individual grant sizes reflect both the $100K annual installment structure and legacy grants from earlier, smaller cycles. Grants to individual organizations range from $15,000 (a special partnership grant to the Foundation for the National Institutes of Health) to $1,862,500 (Boston Children's Hospital cumulatively across 19 individual grants). Most standard awards appear as $82,500, $100,000, or $130,000 disbursements per grant record — consistent with the biannual payment model on grants of varying sizes over time.

The Major Grants program constitutes a separate, higher tier: $450,000 per award over two years ($225,000 annually), currently exclusively focused on Child and Adolescent Mental Health. Notable Major Grant recipients include Trustees of Dartmouth College ($829,750 total, 3 grants), Boston Medical Center ($532,500, 3 grants), and McLean Hospital ($225,000, 1 grant). These awards are not offered every cycle and require different positioning from standard early-career awards.

Asset trajectory signals growing grantmaking capacity. Total foundation assets surged from $66.7 million (FY2022) to $72 million (FY2023) to $101 million (FY2024) — a 40% increase in two years, driven by $28.2 million in FY2024 revenue (primarily investment income). The mandatory 5% minimum distribution on $101 million in assets implies a floor of approximately $5 million in required annual charitable distributions — substantially above the $2.1-2.7 million pace of recent years. This gap suggests the Foundation may be accumulating capacity for expanded grantmaking, new programs such as the MIT Innovation Hub, or Program-Related Investments — all of which could benefit researchers who engage early with the Foundation's evolving strategy.

The Foundation's asset-matched peers (all approximately $101 million in assets) are drawn from the general philanthropy and grantmaking sector and represent a cross-section of mid-sized American foundations. The comparison below highlights how Hood's highly specialized, open-application model contrasts sharply with broader-mandate peers.

The Hood Foundation stands apart from this asset-peer group in three critical respects. First, it operates a fully open, structured, public application process — rare among foundations of this asset size, where invitation-only and relationship-driven grantmaking are more common. Second, its mission specificity is extreme: pediatric health research in New England only, versus the broader-mandate peers which have more diffuse geographic and topical footprints. Third, Hood's payout-to-asset ratio of approximately 2.2% is lower than peer norms, while its recent asset surge to $101 million suggests near-term distribution growth is possible. For early-career pediatric researchers in New England, Hood represents an unusually accessible open-entry funder at the $100M+ asset tier — a combination rarely available in the academic grant landscape.

The most consequential recent development is the April 10, 2025 launch of the Hood Pediatric Innovation Hub at MIT, backed by a $15 million, five-year commitment from the Foundation. Partnering with the MIT Health and Life Sciences Collaborative (MIT HEALS), the Hub is led by faculty director Elazer R. Edelman (MIT Medical Engineering) and executive director Joseph J. Frassica (MIT Institute for Medical Engineering and Science). The initiative explicitly addresses the alarming statistic that only 10% of FDA approvals between 2008 and 2018 were designated for individuals under 18. This represents the Foundation's largest publicly disclosed single commitment and a structural expansion beyond its traditional grant award model.

On February 23, 2026, the Foundation appointed Dr. Camilia ('Cami') R. Martin, MD, MS as Chief Scientific Officer — the first named CSO in the Foundation's recorded history. Dr. Martin's mandate is to steward and advance the child health research portfolio and oversee scientific review of all pediatric research awards. This hire signals a meaningful professionalization of the Foundation's scientific oversight infrastructure.

On February 16, 2026, the Foundation named five researchers as January 2026 Child Health Research Awardees, maintaining its biannual award cadence. August 21, 2025 saw five additional awardees recognized for the July 2025 funding cycle.

On October 23, 2025, the Foundation and MIT co-hosted the 'Explore the Frontiers of Pediatric Innovation' summit at the Museum of Science in Boston — drawing a multidisciplinary audience of students, clinicians, engineers, and researchers, suggesting growing community engagement ambitions beyond the grant portal.

As of March 13, 2026, the Foundation has opened applications for the September 2026 funding cycle, introducing the new two-step Concept Paper process for the first time.

The Hood Foundation has specific procedural requirements that differ meaningfully from NIH or major foundation norms. The following tips are drawn directly from confirmed application guidelines, foundation communications, and grantee patterns.

Confirm career-stage eligibility before anything else. The five-year (PhD) and seven-year (physician-scientist) windows are calculated from the date you began your current independent faculty position — not your degree date or your first postdoc. If you are near either boundary, email Charlene.Mancusi@CharlesHoodFoundation.org to confirm eligibility before investing weeks in an application.

Apply earlier in your career window, not at the end. The Foundation funds early-career researchers as a bridge to R01s and other major federal grants. Applicants who appear to be exiting their eligibility window face implicit questions about how a two-year Hood Award will launch their trajectory. The strongest candidates demonstrate momentum at the beginning of independence, not a last-ditch effort before aging out.

Frame everything as hypothesis-driven and child-health-specific. The scientific review committee penalizes descriptive or purely observational studies without mechanistic hypotheses. Ground every aim in an explicit testable hypothesis, and draw a direct line to improved child health outcomes — not adult medicine extrapolated to children.

Align with the current Major Grant theme if eligible. For FY2025-2026, Major Grants of $450,000 are focused exclusively on Child and Adolescent Mental Health. If your work touches psychiatric, behavioral, or neurodevelopmental disorders in children, a Major Grant application may be more competitive than a standard award.

Secure recommenders immediately upon deciding to apply. Two mandatory letters (Department/Division Chair + Postdoctoral Mentor or Residency Director) must be submitted through the online portal by the deadline — the portal closes at noon Eastern Time, not end of day. You are responsible for monitoring recommender submission status. A late recommender disqualifies your entire application with no recourse.

Prepare for the Concept Paper step (September 2026 and beyond). The new two-stage process requires a brief concept paper summarizing scientific aims, research approach, and child health relevance before full proposal access is granted. Treat this as a competitive filter, not a formality — precision and innovation must be demonstrated in compressed form.

Leverage the one-resubmission policy strategically. If declined, you may resubmit once within one year. Request any available reviewer feedback, address every comment explicitly in the resubmission, and note the changes clearly. The Foundation's willingness to consider resubmissions signals a preference for persistence over abandon.

Monitor competing funding in real time. If you receive any federal or non-federal grant of $500,000 or more in direct costs during Year 1 of a Hood Award cycle, you must notify Charlene Mancusi immediately. This rule applies even if the notification comes after submission.